"d every year in June in Greece and organized by Professor Athanasios D. Giannoukas has become a “must”. This year the meeting was devoted to vascular aneurysms, and the book published in 2009 by the organizer in collaboration with Frans L. Moll, Piergiorgio Ciao, and Martin Veller deserves both mention and analysis. The 400-page hardback book in glazed paper contains contributions by 84 authors and is divided into 6 richly illustrated and referenced chapters. As stated in the preface, vascular aneurysms, including arterial and venous, are mul"

Full text

"ates the global landscape of vascular interventions and has become a catchphrase for determination of the acceptable standard. Its tools allow us to stratify disease and therapy. In his 1996 presidential address to the Society of Vascular Surgery, Rutherford stated: “The results of therapy for vascular diseases have little meaning if presented in isolation, no matter how uniform and valid the criteria used for reporting them. They are intended to be compared with something.”1 For vascular specialists who strive to find something better for their patients and are willing to change based on "

Full text

"T The last fifteen years have witnessed a rapid deepening of our understanding of both the molecular biology of lymphatic vessels and the formation of new lymphatic vessels during lymphangiogenesis. Following the discovery that VEGFR-3, a transmembrane receptor tyrosine kinase, localizes to lymphatic vessels and can orchestrate lymphangiogenesis, the list of molecular regulators of lymphangiogenesis has continued to grow, and includes growth factors, cell surface proteins, and transcription factors. In addition, molecules have been identified that are specifically expressed on lymphatic endot"

Full text

"on but potentially progressive. Despite this, it is acknowledged that CVD is usually overlooked both by doctors who underdiagnose the condition and by patients themselves who rarely consult spontaneously for venous leg problems except in the advanced stages.2 As a consequence, CVD is undertreated, particularly in the early stages. CVD may be associated with a wide range of lower limb symptoms, which may be present from the outset even before any visible signs of CVD have been identified. Therefore, patients’ queries about leg symptoms and their variability with position might be the best way"

Full text

"ound in a moist environment. Modern dressings are occlusive or semi-occlusive, classified according to their physical composition. Published systematic reviews of the value of different types of dressings in the management of chronic wounds provide only weak levels of evidence of their clinical efficacy, in terms of healing rate. Nevertheless, the indications for modern dressings were recently determined according to a systematic review of the literature and to a formal consensus process. Despite the lack of appropriate studies, modern dressings remain a part of the standard of care and are wi"

Full text

"ow do we (i) treat VTE once a diagnosis is confirmed? (ii) assess the risk of VTE, and (iii) manage women with a high risk of VTE? When anticoagulants are required in pregnancy and the puerperium, low-molecular-weight heparin (LMWH) is now the preferred drug, but optimal dosage and monitoring remain unresolved issues. In addition, there is a paucity of reliable information about the risk of VTE in women with thrombophilia (asymptomatic or with a previous deep venous thrombosis or pulmonary embolism). Recommendations and limitations of the literature are highlighted. INTRODUCTION Pulmonary "

Full text

"ed controlled trials in this field are lacking for obvious reasons. Christine Biron-Andreani of the Hematology Unit of the University Hospital in Montpellier gives us a survey of practically very useful, updated recommendations, concerning both prevention and treatment of venous thromboembolic disease, in accordance with the recent ACCP guidelines and supported by numerous references. The choice of a proper wound dressing in venous leg ulcers has become an art. The article by Patricia Senet, Hôpital Tenon, Paris, offers a remarkable overview of local wound dressings on the market, including b"

Full text

"icia Senet - Phlebolymphology - 2010 ; 17 (2): 87 Results from detection surveys on chronic venous disease in Eastern Europe Françoise Pitsch - Phlebolymphology - 2010 ; 17 (2): 95 Understanding the mechanisms of lymphangiogenesis: a hope for cancer therapy? Jonathan P. Sleeman - Phlebolymphology - 2010 ; 17 (2): 99 Venous Clinical Severity Score and quality-of-life assessment tools: application to vein practice Michael A. Vasquez, Carolyn E. Munschauer - Phlebolymphology - 2010 ; 17 (2): 108 ABOUT NEW ARTICLES AND BOOKS A review by Michel Perrin Phlebolymphology - 2010 ; 17 "

Full text